Cargando…

A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients

This retrospective cohort study investigated the progression risk of sequential complication in Asian type 2 diabetes (T2D) patients using the Taiwan Pay-for-Performance Diabetes Registry and claim data from November 2003 to February 2009. 226,310 adult T2D patients without complication were followe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Li-Jen, Chen, Jeng-Huei, Lin, Ming-Yen, Chen, Li-Chia, Lao, Chun-Huan, Luh, Hsing, Hwang, Shang-Jyh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623532/
https://www.ncbi.nlm.nih.gov/pubmed/26507664
http://dx.doi.org/10.1038/srep15687
_version_ 1782397697183973376
author Cheng, Li-Jen
Chen, Jeng-Huei
Lin, Ming-Yen
Chen, Li-Chia
Lao, Chun-Huan
Luh, Hsing
Hwang, Shang-Jyh
author_facet Cheng, Li-Jen
Chen, Jeng-Huei
Lin, Ming-Yen
Chen, Li-Chia
Lao, Chun-Huan
Luh, Hsing
Hwang, Shang-Jyh
author_sort Cheng, Li-Jen
collection PubMed
description This retrospective cohort study investigated the progression risk of sequential complication in Asian type 2 diabetes (T2D) patients using the Taiwan Pay-for-Performance Diabetes Registry and claim data from November 2003 to February 2009. 226,310 adult T2D patients without complication were followed from diagnosis to complications, including myocardial infarction (MI), other ischemic heart disease (IHD), congestive heart failure (CHF), stroke, chronic kidney disease (CKD), retinopathy, amputation, death or to the end of study. Cumulative incidences (CIs) of first and second complications were analyzed in 30 and 4 years using the cumulative incidence competing risk method. IHD (29.8%), CKD (24.5%) and stroke (16.0%) are the most common first complications. The further development of T2D complications depends on a patient’s existing complication profiles. Patients who initially developed cardiovascular complications had a higher risk (9.2% to 24.4%) of developing IHD or CKD, respectively. All-cause mortality was the most likely consequence for patients with a prior MI (12.0%), so as stroke in patients with a prior MI (10.8%) or IHD (8.9%). Patients with CKD had higher risk of developing IHD (16.3%), stroke (8.9%) and all-cause mortality (8.7%) than end-stage renal disease (4.0%). Following an amputation, patients had a considerable risk of all-cause mortality (42.1%).
format Online
Article
Text
id pubmed-4623532
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46235322015-11-03 A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients Cheng, Li-Jen Chen, Jeng-Huei Lin, Ming-Yen Chen, Li-Chia Lao, Chun-Huan Luh, Hsing Hwang, Shang-Jyh Sci Rep Article This retrospective cohort study investigated the progression risk of sequential complication in Asian type 2 diabetes (T2D) patients using the Taiwan Pay-for-Performance Diabetes Registry and claim data from November 2003 to February 2009. 226,310 adult T2D patients without complication were followed from diagnosis to complications, including myocardial infarction (MI), other ischemic heart disease (IHD), congestive heart failure (CHF), stroke, chronic kidney disease (CKD), retinopathy, amputation, death or to the end of study. Cumulative incidences (CIs) of first and second complications were analyzed in 30 and 4 years using the cumulative incidence competing risk method. IHD (29.8%), CKD (24.5%) and stroke (16.0%) are the most common first complications. The further development of T2D complications depends on a patient’s existing complication profiles. Patients who initially developed cardiovascular complications had a higher risk (9.2% to 24.4%) of developing IHD or CKD, respectively. All-cause mortality was the most likely consequence for patients with a prior MI (12.0%), so as stroke in patients with a prior MI (10.8%) or IHD (8.9%). Patients with CKD had higher risk of developing IHD (16.3%), stroke (8.9%) and all-cause mortality (8.7%) than end-stage renal disease (4.0%). Following an amputation, patients had a considerable risk of all-cause mortality (42.1%). Nature Publishing Group 2015-10-28 /pmc/articles/PMC4623532/ /pubmed/26507664 http://dx.doi.org/10.1038/srep15687 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Cheng, Li-Jen
Chen, Jeng-Huei
Lin, Ming-Yen
Chen, Li-Chia
Lao, Chun-Huan
Luh, Hsing
Hwang, Shang-Jyh
A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients
title A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients
title_full A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients
title_fullStr A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients
title_full_unstemmed A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients
title_short A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients
title_sort competing risk analysis of sequential complication development in asian type 2 diabetes mellitus patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623532/
https://www.ncbi.nlm.nih.gov/pubmed/26507664
http://dx.doi.org/10.1038/srep15687
work_keys_str_mv AT chenglijen acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT chenjenghuei acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT linmingyen acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT chenlichia acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT laochunhuan acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT luhhsing acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT hwangshangjyh acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT chenglijen competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT chenjenghuei competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT linmingyen competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT chenlichia competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT laochunhuan competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT luhhsing competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients
AT hwangshangjyh competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients